- Home
- KMDA vs TACH Comparison
KMDA vs TACH Comparison
Compare KMDA & TACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- TACH
- Stock Information
- Founded
- KMDA 1990
- TACH 2024
- Country
- KMDA Israel
- TACH United States
- Employees
- KMDA N/A
- TACH N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- TACH
- Sector
- KMDA Health Care
- TACH
- Exchange
- KMDA Nasdaq
- TACH Nasdaq
- Market Cap
- KMDA 399.7M
- TACH 345.7M
- IPO Year
- KMDA N/A
- TACH 2025
- Fundamental
- Price
- KMDA $7.74
- TACH $10.08
- Analyst Decision
- KMDA Strong Buy
- TACH
- Analyst Count
- KMDA 3
- TACH 0
- Target Price
- KMDA $14.67
- TACH N/A
- AVG Volume (30 Days)
- KMDA 83.7K
- TACH 6.5K
- Earning Date
- KMDA 08-13-2025
- TACH 01-01-0001
- Dividend Yield
- KMDA 2.56%
- TACH N/A
- EPS Growth
- KMDA 31.21
- TACH N/A
- EPS
- KMDA 0.28
- TACH N/A
- Revenue
- KMDA $167,235,000.00
- TACH N/A
- Revenue This Year
- KMDA $14.51
- TACH N/A
- Revenue Next Year
- KMDA $9.31
- TACH N/A
- P/E Ratio
- KMDA $27.53
- TACH N/A
- Revenue Growth
- KMDA 11.83
- TACH N/A
- 52 Week Low
- KMDA $4.93
- TACH $9.51
- 52 Week High
- KMDA $9.16
- TACH $11.00
- Technical
- Relative Strength Index (RSI)
- KMDA 66.78
- TACH N/A
- Support Level
- KMDA $7.68
- TACH N/A
- Resistance Level
- KMDA $7.86
- TACH N/A
- Average True Range (ATR)
- KMDA 0.21
- TACH 0.00
- MACD
- KMDA 0.05
- TACH 0.00
- Stochastic Oscillator
- KMDA 67.61
- TACH 0.00
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.